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Abdominal sepsis
glomerular disease and 609
Acetate, plasma
and acid-base changes in children on hemodialy-
sis 70
Acetazolamide
effect on bicarbonate reabsorption by papillary
collecting duct (abst) 254
effect on deep nephrons and distal structures
(abst) 237
Acetylcholine
effect on early phase of acute renal failure 399
Acid-base metabolism
during hemodialysis in children 70
Acid excretion
of adrenalectomized rat 516
Acidosis
acute unilateral nephrectomy and (abst) 237
effect on luminal and antiluminal transport
(abst) 226
effect on potassium delivery to end-descending
limb of juxtamedullary nephron (abst) 255
from paint sniffing (abst) 139
hyperkalemic, hyperchloremic a. (abst) 119, 120
interorgan control of (abst) 228
nephron sites of ammonia addition in (abst) 255
of distal tubule, pathogenesis 1
role of PTH in (abst) 110, 114
renal adaption to, in chicken (abst) 389
renal glutamate dehydrogenase pathway in 540
Adrenalectomy
renal net acid excretion after 516
vasopressin-sensitive cAMP in (abst) 203
Aldosterone
binding sites for, in rabbit nephron (abst) 246
effect on sodium transport and citrate synthase
activity (abst) 245
effect on transepithelial PD of distal tubule 678
in acid-base balance (abst) 225
target sites for, in renal medulla (abst) 248
Alkaline phosphatase
in nephrotic syndrome 710
Aluminum
removal by hemodialysis 587
Amantadine hydrochloride
renal function impaired with (abst) 140
American Society of Nephrology
1979 abstract rating for (abst) 129
Amiloride
to study distal nephron hydrogen ion secretion
(abst) 394
to treat Bartter's syndrome and Liddle's syn-
drome (abst) 127
Aminonucleoside
and renal disease (abst) 198
Aminoglycosides
effect on glomerular function 288
nephrotoxicity from; micropuncture study of 416
renal transport of (abst) 252
Ammonia, renal
genesis of (abst) 224, 225
in medullary collecting duct 281
micromethod to measure 80
Angioplasty, percutaneous transluminal
blood pressure and renin secretion before and af-
ter (abst) 176
Angiotensin
prostaglandins' effect on 250 (abst), 816, 822
receptors for, in glomeruli vs. arterioles 687
Angiotensin II
altered sodium balance effect on (abst) 394
desensitization of renal vasculature to (abst) 172
furosemide as competitive inhibitor of (abst) 166
receptors in rat mesangial cells (abst) 163
Antibody, see also Immunology
to rat Fx1A (abst) 179
Antidiuretic hormone
action in down-regulation of sodium chloride
transport in medullary thick ascending limbs
(abst) 244
inappropriate secretion of; volume-dependency of
(abst) 388
natriuresis in hypophysectomized dogs and (abst). 230
prostaglandins' effect on 831, 839, 851
Antiinflammatory agents, nonsteroidal




to modify progressive renal ablation nephropathy
(abst) 193
Antishock trousers
to stimulate renal effects of weightlessness
(abst) 124
Antithymocyte globulin
in cadaver kidney transplantation 438
Arginine vasopressin, see also Vasopressin
and cellular calcium uptake (abst) 244
hemodynamic response of, in health (abst) 165
inhibitor of vascular effects of (abst) 229
Arterioles, renal
angiotensin receptors in, vs. those in glomeruli . . ..687
Aspirin
renal effects of (abst) 103
Autologous immune complex nephritis
modulation of by preimmunization (abst) 181
Azotemia
and diuretic therapy; role of urea production in
(abst) 205
hyperkalemia and hypoaldosteronism during con-
verting enzyme inhibition in (abst) 175
xxiv Subject Index: Vol. 19
Bacteria
antibody-coating of; in urine of patients with py-
elonephritis 65
in urinary tract disease; related to renal disease ....58
Bartter's syndrome
chloride-leak hypothesis reevaluated in (abst) 137
prostaglandins and 87
Berger's disease, see IgA nephropathy
Bradykinin
role in renal interstitial pressure (abst) 244
Brush border membrane
carbonic anhydrase activity in (abst) 256
energy-dependent binding of All to (abst) 235
Brush border vesicles
chloride transport pathways in (abst) 261
Cadmium nephropathy
molecular basis for (abst) 210
Calcium
cyclic nucleotides and prostaglandins' effect on,
in toad bladder (abst) 117
in phosphate reabsorption after transplantation .... 568
prostaglandins' effect on cellular uptake of 15
Calcium nephrolithiasis
crystal nucleation and (abst) 114
Captopril
during hemorrhagic hypotension (abst) 388
effect on isolated perfused rat kidney (abst) 175
leukopenia and (abst) 169
Carbonic anhydrase cells
of turtle urinary bladder 491
Cardiac glycosides
effect on renal and cardiac Na-K-ATPase (abst) ...204
Cardiac surgery
glomerular filtration following (abst) 133
Catecholamines
adrenergic and dopaminergic receptors for
(abst) 239
effect in mouse thick ascending limb of Henle's
loop (abst) 253
renal function and patterns in excretion of (abst) .. 168
Cationic charge
as determinant in nephrotoxicity 424
Cell culture
of transporting renal epithelial monolayer 465
Cephalexin
to prevent peritonitis in dialysis (abst) 392
Chiorambucil
long-term effects of, in nephrotic syndrome of
childhood (abst) 135
Chloride transport
cisplatin effects on 8
in type II pseudohypoaldosteronism 716
Cimetidine
effect on uremia (abst) Ill
Cirrhosis
role of prostaglandins in (abst) 218
Cisplatin
effects on epithelial transport 8
Clonidine
withdrawal of, in dialysis (abst) 174
Concentrating defect
in potassium depletion, role of papillary plasma
flow (abst) 252
Cortex, renal
gluconeogenesis, and NAD in (abst) 221
Cortex, superficial
PAH short circuited in (abst) 228
Cortical collecting ducts
bicarbonate secretion by (abst) 233
Cyclophosphamide
effect in autologous immune complex glomerulo-
nephritis (abst) 180, 389
effect on steroid-dependent nephrotic syndrome
in children 454
hemodialyzability of (abst) 154
Cyclosporin A
mechanisms of immunosuppression (abst) 389
Cytochalasins
reversible alteration in peritoneal permeability by
(abst) 155
Denervation, renal
diuresis and natriuresis in conscious dogs with
(abst) 255
Deoxycorticosterone acetate (DOCA)
effect in potassium-depleted rats (abst) 251
Diabetes
ADH and PGE2 effects on medulla in (abst) 220
continuous ambulatory peritoneal dialysis in
(abst) 391
d. insipidus
ADH-dependent nephron heterogeneity in he-
reditary hypothalamic type of (abst) 260
d. mellitus
glomerular hemodynamics in 410
d. nephropathy
coronary angiography effect on (abst) 135
hyperkalemia and, role of renin (abst) 178
model for; drug-induced (abst) 215
prevention by diet (abst) 186
renin-angiotensin-aldosterone system in
(abst) 138
retinopathy with (abst) 125
ketone bodies and (abst) 391
proteinuria and glycosuria in (abst) 211
Dialysis, see also Hemodialysis, Hemofiltration,
Hemoperfusion
acetate dialysate for
and succinate (abst) 151
hypoxemia during (abst) 140
vs. bicarbonate in (abst) 144, 161
at home (abst) 392
bicarbonate dialysate for; hypoxemia during
(abst) 140
body heme turnover in (abst) 211
diabetes and
glycosylated hemoglobins in (abst) 160
hyperglycemia in (abst) 141
effect of dialysate sodium and fluid removal
(abst) 161
ethanol and (abst) 160
exclusion from; sociologic and legal
perspective 739
hepatitis profiles in (abst) 160
hypertension in; treated by captopril (abst) 142
and hypotension, etiology and prevention
(abst) 148, 393
Subject Index: Vol. 19 XXV
early correction of (abst) 156
hypoxemia with
leukopenia and dialysate composition's effect
on (abst) 147
lipids in 625
manganese toxicity in, with pancreatitis (abst) 395
middle molecule hypothesis modified (abst) 159
nitrosodimethylamine and (abst) 159
osteomalacia and
normal bone scan in (abst) 394
secondary to aluminum toxicity in (abst) 149
recirculation in superior vena cava with 2-needles
and (abst) 143
Redy vs. single-pass (abst) 390
rehabilitation status of American patients on
(abst) 147
self-dialysis; successful use of (abst) 150
siderosis from (abst) 141
Dialysis, peritoneal
arachidonic acid and PGE2's effect on (abst) 146
automated delivery machine to prepare sterile bi-
carbonate dialysate for (abst) 149
automated long-cycle type of (abst) 144
continuous ambulatory pd.
amino acid losses during (abst) 152
complications of (abst) 153
drainage volumes, clearances, glucose absorp-
tion, and protein losses in (abst) 160
during peritonitis (abst) 157
glucose absorption during 564
in children (abst) 162
in high-risk patients with renal failure (abst) 155
in uremic rabbits (abst) 146
massive pleural effusion secondary to (abst) 152
nitrogen balance in (abst) 144
PTH and mineral metabolism in (abst) 145
surface sterilization of tubing for (abst) 150
vs. intermittent pd. (abst) 153
continuous cycle type of (abst) 145
convective vs. diffusive solute removal (luring
(abst) 155
diabetes and (abst) 146, 162
during peritonitis (abst) 141, 158, 460
filters to reject protein and bacteria during
(abst) 145
imidazole and (abst) 143
peritoneal-fluid eosinophilia in (abst) 149
prostaglandin's effect on (abst) 146, 148
protein losses during 593
pulmonary function testing during (abst) 140
pseudomembranous colitis and cloudy peritoneal
drainage in (abst) 148
refractory hemodialysis ascites treated by (abst) ...149




safety and efficacy of 728
reuse of (abst) 392
sorbent suspension d.; microprocessor control of
(abst) 142
cis-Diamminedichloroplatinum
long-term pathologic effects of (abst) 181
nephrotoxicity of; pressure flows in initial phase
of(abst) 213
Dichioromethylene diphosphonate




effect on vasopressin-sensitive adenylate cyclase
(abst) 236
Diuretics
abuse of; and idiopathic edema 881
effects on body fluid composition (abst) 164
effect on thick ascending limb Na-K-ATPase ac-
tivity (abst) 231
Dopamine
effect on fluid reabsorption in straight portions of
proximal tubules (abst) 244
effect of sodium intake on renal receptors for
(abst) 245
Dopamine 3-hydroxylase
myocardial function and (abst) 177
Duodenal mucosa
in renal failure 324
Dysautonomia
renal functional impairment in (abst) 137
Edema, idiopathic
role of diuretic abuse in 881
Electrophysiology
of distal tubule, electrode techniques 24
Epithelium, renal
cisplatin's effects on 8
effect of vasopressin and actin filaments on (abst). 230
in vivo culture of tubular 465
of turtle urinary bladder 491
prostaglandins' effect on electrolyte transport
at 791
sodium chloride and osmotic force in (ahst) 235
sodium to induce growth of (abst) 227
Epinephrine
effect on distal tubular potassium secretion (abst) .237
Escherichia coli
in immunology of pyelonephritis 297
Estrogen
effects in normal and pyelonephritic rat kidney
(abst) 104
Fabry's disease
and renal failure (abst) 136
Fanconi syndrome
proline transport and (abst) 249
Fasting
and renal adaptation to dietary amino acid
change (abst) 240
Fatty acids
and renal function (abst) 221
Ferritin
uptake in nephron, influence of charge on
(abst) 248
Fibrinolytic enzyme
lysis of occlusive renal pelvic blood clot by (abst). 135
Fibronectin
antibodies to (abst) 193
Furosemide
effect on acute renal failure induced by cis-diam-
minedichioroplatinum (abst) 20!
effect on distal tubule (abst) 165, 250
xxvi Subject Index: Vol. /9
Genetic studies
of systemic lupus erythematosus 474
Gentamicin
acquired insensitivity to (abst) 199
effect on glomerular function 288
micropuncture study of rat kidney's handling of .. .416
nephrotoxicity of
brush border membrane receptors for (abst) 213
cortex electrolyte content and Na-K-ATPase
activity in (abst) 197
subcellular morphologic changes in (abst) 212
PAH transport and (abst) 194
tubular sites of accumulation of 529
uptake by polycations (abst) 222
Glomerular disease
and abdominal sepsis 609
diagnosis when two diseases coexist (abst) 178
Glomerular dysmembranosis
chronic gross hematuria and (abst) 139
Glomerular sclerosis
intraglomerular thrombosis preceding (abst) 128
Glomerulonephritis
endothelial cell in vitro study of (abst) 182
focal segmental g. with unilateral renal agenesis
(abst) 185
glomerular leakage of proteins in, immunoenzy-
matic study 663
HBsAg glomerular deposits in 579
hypertension's effect on (abst) 188
idiopathic acute crescentic rapidly progressive g.;
pulse methyiprednisolone therapy for (abst) 120
IgA mesangial g.; genetic study of (abst) 134
immune complex g.
abrogation of (abst) 193
PGE to alter (abst) 187
in systemic vasculitis: treatment and outcome
(abst) 486
malarial g.; immune complexes and (abst) 192
membraneous g.; Waldenstrom's macroglobulin-
emia and (abst) 190
membranoproliferative g., type III; clinicopatho-
logic study of (abst) 178
nonspecific g.
immunosuppressive therapy for (abst) 104
poststreptococcal g.; long-term prognosis of
(abst) 136
rapidly progressive g.
megadose methylprednisolone vs. plasmaphe-
resis for (abst) 121
Glomerulotubular nephropathy
genetics and (abst) 188
Glomerulus
angiotensin receptors in, vs. receptors in arter-
ioles 687
capillary hydraulic pressure of; overestimated by
stop-flow pressure measurement (abst) 245
clearing of macromolecules by, with ferritin
(abst) 184
effect of mercuric chloride and uranyl nitrate on
ultrafiltration coefficient in (abst) 236
epithelial cells of
anionic sialoproteins from 553
filtration differences in rat and dog (abst) 209
g. filtration rate
during complete ureteral obstruction in rats 603
new method to measure (abst) 250
prostaglandins' effect on 802
hemodynamics of, in aged rats (abst) 195
in Heymann nephritis and puromycin aminonu-
cleoside nephrosis (abst) 191
isolated perfusion of (abst) 251
light emission by (abst) 226
lymphokine infusion and histology of (abst) 191
network thermodynamic model of 359
of aminoglycoside-treated rats 288
oxygen-free prostaglandin production by (abst) 219
polyanions' role in (abst) 216
synthesis of charge barrier components by
(abst) 182
ultrafiltration coefficient of; effect of salt deple-
tion and hemorrhage on (abst) 254
Glucagon
as regulator of potassium excretion in sheep
(abst) 253
effect in early streptozotocin diabetes (abst) 221
Glucocorticoid therapy
and osteopenia (abst) 114
skeletal cAMP response to PTH in (abst) 206
Glucose absorption
during continuous ambulatory peritoneal
dialysis 564
Glutamate dehydrogenase
in intact acidotic dog 225 (abst), 540
Glutamate ('4C-)
to measure renal ammonia 80
Goodpasture's disease
in rabbit (abst) 183
Growth factors, renal




growth failure and renal tubular acidosis in (abst). 124
Heart failure
in uremia, trace elements in (abst) 210
Hemodialysis, see also Dialysis
access morbidity of (abst) 141
acetate h., adverse ocular effects of (abst) 157
acetate and bicarbonate h., oxygen consumption
and respiratory quotient during (abst) 145
ambulatory blood pressure monitoring in (abst) . . .151
androgen-induced hepatocell carcinoma in (abst)... 105
and sequential ultrafiltration; myocardial per-
formance during (abst) 154
ascites with, in anephric patients (abst) 156
chronic h.
calcium carbonate and hypercalcemia in
(abst) 195
oxidative burst in infection during (abst) 157
polymorphonuclear leukocytes in 349
sex, work status, and survival in (abst) 153
cimetidine therapy and, for tertiary hyperpara-
thyroidism (abst) 143
endemoepidemic hepatitis B with (abst) 151
fluoride intoxication in (abst) 154
for chronic renal failure
dipyridamole and 103
effect of proteins and diet during (abst) 105
Subject Index: Vol. 19 Xxvii
endocrine function tests in (abst) 103
lipoprotein changes in (abst) 104
serum cAMP levels and (abst) 103
in children; acid-base metabolism in 70
maintenance h.
cessation of anabolic steroids in (abst) 158
high hematocrit in (abst) 144
legionella pneumophila and Pittsburgh pneumo-
nia in patients on (abst) 151
long-term survival on (abst) 142
mannitol-induced diarrhea for excessive weight
gain in (abst) 148
myocardial abnormalities with (abst) 150
nutritional status in patients on (abst) 161
pericardial effusion treatment during (abst) 156
PGI2 substitution for heparin in (abst) 159
non-A non-B hepatitis in (abst) 152
osteomalacia and; aluminum intoxication in (abst). 115
PGE blood levels during (abst) 158
saliva zinc and taste acuity in (abst) 159
sleep apnea during (abst) 162
sorbent regenerative system of; acute respiratory
acidosis with (abst) 147
to remove aluminum 587
vs. peritoneal dialysis 341
prostacyclin and heparin's effect on (abst) 147, 162
vagal neuropathy in nondiabetic patients on
(abst) 122
Hemofiltration
lipoprotein lipase inhibitor removal during (abst). .154
plasma calcium and PTH during (abst) 156
vs. hemodialysis; to study postdilutional sodium
flux (abst) 146
Hemoperfusion
coated-charcoal h.; for drug intoxication (abst) 391
Henoch-Schönlein purpura
circulating IgA immune complexes in (abst) 485
Henoch Schönlein syndrome nephriti s
immunoregulatory abnormalities in (abst) 180
Heparin
during dialysis; variable requirements of (abst) 392
Hepatitis B virus
immune response to (abst) 191
in glomerulonephritis 579
Heymann nephritis
brush border antigen lacking in (abst) 187
cyclosporin A to prevent (abst) 185
incomplete Freund's adjuvant to induce tolerance
to (abst) 185
passive H.n.; new glomerular antigen in (abst) 183
reimmunization with Fx IA and tubular damage in
(abst) 188
role of age in (abst) 184
subepithelial immune deposits in (abst) 186
Hippuran clearance
vs. PAH to assess renal plasma flow 49
HLA typing
in benign familial hematuria and Alport's syn-
drome (abst) 394
Homocystine
uptake by rat cortical tubules (abst) 240
Hydralazine
renal disease and (abst) 198
Hydrogen ion pump
ATP synthesis and (abst) 228
Hydrogen ion secretion
acidemia and, in distal nephron of dog (abst) 242
control of, in distal nephron (abst) 242
in distal tubule in acidosis 1
in distal tubule of hypothyroid rat (abst) 250
in turtle urinary bladder 491
vanadate and, in turtle bladder (abst) 230
Hydronephrosis
cortical PG synthesis and (abst) 198
Hypercalcemia
and renal acid handling (abst) Ill
Hypercalciuria
renal calcium leak in (abst) 134
Hyperkalemia
chronic h.; chloride absorption in siblings with
(abst) 121
mineralocorticoid-resistant h. without salt wast-
ing; chloride reabsorption in 716
Hyperparathyroidism, familial hypocalciuric
furosemide and hydrochlorothiazide's effects on
(abst) 118
Hypertension
Al and All in (abst) 163
abnormal renal angiogram with (abst) 128
calcium intake in (abst) 165
diabetes and; effects of potassium-wasting diuret-
ics on (abst) 172
essential h.
beta-blocking therapy and (abst) 165
chlorthalidone in, to study blood pressure re-
sponse (abst) 174
low-renin type; diuretic therapy for (abst) 166
sodium intake and plasma norepinephrine in
(abst) 164
guanabenz and hydrochiorothiazide in (abst) 177
hyperparathyroidism and (abst) 169
hypomagnesemia in (abst) 164
iatrogenic h.; in postmenopausal osteoporosis
(abst) 123
kallikrein-kinin system and (abst) 169
neonatally induced, hemodynamic profiles in
(abst) 163
obesity and (abst) 174
of middle age, effects of low sodium intake, di-
uretics, and propranolol (abst) 173
parathyroidectomy and, effect on urinary electro-
lyte excretion (abst) 263
PGE2 and (abst) 176
renin-aldosterone system in 445
renin and prostaglandins in (abst) 178
renovascular h.
bradykinin and PGE in (abst) 172
medical vs. surgical therapy for (abst) 167
renography to assess renal plasma l!ow in 49
spontaneous h.
calcium metabolism and PTH function in (abst). 172
parathyroidectomy and (abst) 176
renal hemodynamics in young with (abst) 175
renal vascular resistance in (abst) 168
unilateral renal h.; catecholarnines, sodium,
and renin in (abst) 177
urinary kallikrein in, after transplantation
(abst) 163
xxViu Subject Index: Vol. 19
Hypertonic solutions
and roentgen contrast agents, renal vascular re-
sponses to (abst) 246
Hyperventilation, acute
hypophosphatemia and (abst) 113
Hypoproteinemia
effect on jejunal absorption in purine aminonu-
cleoside nephrotic rats (abst) 249
Hypotension
in anephric patients (abst) 135
hemorrhagic h.; captopril's effects on (abst) 196
Immune complexes
before and after renal transplantation 332
lumen-mesangial transfer of (abst) 184
ic. glomerulopathy induced by mercury; immun-
oregulation and antinuclear antibodies in (abst) .485
in urine, diagnostic value (abst) 181
Immunoenzymatic study
of glomerular protein leakage in glomerulonephri-
tis 663
Immunoglobulin A
in glomeruli of patients with nephritis (abst) 180
Immunoglobulin A nephropathy (Berger's disease)
circulating immune complexes and deposits in
(abst) 189
complement component and proteins in (abst) 193
immune abnormalities in (abst) 191
Immunoglobulins
and protein loss during peritoneal dialysis 593
Immunology
antibody-coating of bacteria in urine 65
assay for circulating immune complexes (abst) 189
of cultured tubular cells 275
of glomerular basement membrane (abst) 182, 393
of glomerular injury, role for synergism (abst) 187
of Ia antigens in mouse kidney (abst) 391
of minimal change nephrotic syndrome, focal gb-
merulosclerosis, and systemic lupus erythemat-
osus (abst) 180
of pyelonephritis, with live vs. heat-killed bacte-
ria 297
of systemic lupus erythematosus 474
of T-cell-mediated immunity to hapten-conjugat-
ed renal cells (abst) 181
of tubular epithebial antigen and glomerular per-
meability (abst) 190
Immunosuppression
malakoplakia secondary to (abst) 388
Indomethacin
effects on diseased kidney before and after re-




metabolism in renal uptake of (abst) 222
secreted from islet cells obtained in uremia (abst). 228
Iodine 123 hippuran renography
to assess renal plasma flow 49
lothalamate clearance
to study nephrotoxicity of tobramycin and genta-
micin (abst) 130
Ischemia
ATP-magnesium chloride and recovery from
(abst) 200
effect of perfusate calcium on (abst) 196
Kallikrein-kinin system
after unilateral renal artery constriction (abst) 170
effect of Al on, in urine (abst) 170
prostaglandins effect on, 252 (abst) 860, 869
a-Ketoglutarate dehydrogenase
in pH control of kidney (abst) 226
Kidney stones
analysis of, as predictor of urine chemistry (abst) .389
Lactic dehydrogenase and its isoenzymes
in hydronephrotic kidney (abst) 224
in nephrotic syndrome 710
Leukocytes
function of, in chronic dialysis patients 349
Lipid A
in immunology of tubular cells 275
Lipids
in uremia, dialysis, and transplantation 625
Lithium therapy
and the kidney 374
lesion of cortical collecting tubules with (abst) 185
nephrotoxicity of (abst) 129
polyuria induced by, morphology (abst) 200
urinary acidification indices of (abst) 130
Lupus erythematosus, systemic
immunologic and genetic aspects of 474
serologic features and glomerular pathology in
(abst) 190
with diffuse proliferative glomerubonephritis,
monthly plasmapheresis for (abst) 389
Lupus nephritis, see Nephritis, lupus
Magnesium, serum
in acute respiratory alkalosis and acidosis
(abst) 109
Maleic acid
and tubular necrosis (abst) 192
Mannitol
and mechanism of osmotic diuresis 431
Medullary collecting duct
ammonia added into 281
urea reabsorption in, with low protein diet and
urea infusion (abst) 262
Membrane physiology
and sodium-sugar cotransport system (abst) 253
and solute accessibility during incubation (abst) .. .220
basolateral membrane of toad; sodium-calcium
exchange in (abst) 236
chloride transport in, in necturus renal microvil-
lus vesicles (abst) 257
imidoesters to reverse vasopressin's action on
(abst) 254
insulin degradation and (abst) 227
Membranous nephropathy
antibody charge and subepithelial immune depos-
its in (abst) 186
role of electric charge in (abst) 183
Mercuric chloride nephrotoxicity
mitochondrial dysfunction in (abst) 216
Mevalonic acid
in nephrotic hypercholesterolemia (abst) 222
Subject Index: Vol. 19 xxix
Mineralocorticoids
and type II pseudohypoaldosteronism; chloride
transport in 716
Mitochondria
cortical m; pH gradient in (abst) 223
damage in nephrotoxicity 424
Molecular weight markers
distribution of, in postglomerular circulation
(abst) 260
Multiple myeloma
renal failure and (abst) 214
Myocardial infarcts
glomerular dynamics in (abst) 203
Myoglobin
nephrotoxicity of (abst) 200
Natriuresis
head-out water immersion in awake dog and
(abst) 240
Natriuretic factor
purification of (abst) 247
Nephrectomy
partial n; magnesium adaptation in (abst) 207
potassium uptake during potassium infusion and
(abst) 215
role of luminal membrane in reduced mass from
(abst) 203
uninephrectomy; compensatory adaptation to, in
newborn (abst) 196
Nephritic syndrome, acute
renin-aldosterone system in 445
Nephritis
hereditary n.; glomerular basal lamina changes in
(abst) 621
interstitial n.
acute i.n. due to drugs (abst) 131
antibody-dependent cellular cytotoxicity in
(abst) 189
suppressed by autologous anti-idiotypic immu-
nity (abst) 188
lupus n.
cyclophosphamide plus azathioprine (abst) 119
high fat diet in mice with (abst) 184
immunoglobulin deposition in skin to confirm
(abst) 135
plasmapheresis for, without circulating immune
complexes (abst) 126
renal vascular lesions in normotensive patients
with (abst) 179
segmental necrotizing type of (abst) 126
total lymphoid irradiation and (abst) 186
Nephrocalcinosis
phosphocitrate's effects on (abst) 117
Nephron
distal n.
damage of, during isolated kidney perfusion 638
structure-function study of, in rat 36
filtration rate
auto regulation of (abst) 256
in experimental diabetes mellitus 410
in ischemic acute renal failure in dog 503
handling of gentamicin 416
Nephropathy
minimal change n.
cyclophosphamide's effect on lymphocyte
function during remission of (abst) 620
obstructive n.
isolated nephron segments in model of (abst) .. . .202
prostaglandins and vascular tone in 786
sickle cell n.; indomethacin's effects on (abst) 128
Nephrotic syndrome
immune deficiency in (abst) 190
in elderly; incidence of malignancy in (abst) 127
lactic dehydrogenase, its isoenzymes, and alka-
line phosphatase in 133 (abst), 710
liver metabolism in (abst) 138
minimal change n.s.; circulating immune com-
plexes in (abst) 620
no bone disease with normal renal function in
(abst) 130
sodium retention in (abst) 197
steroid-dependent n.s. in children; cyclophospha-
mide's effect on histopathology and relapses of. 454
Nephrotoxicity
of gentamicin; sites of accumulation 529
of netilmicin and amikacin (abst) 125
Nerves, renal
tubular secretion of norepinephrine released from
(abst) 262
Nil disease
and focal glomerular sclerosis with Hodgkin's
lymphoma (abst) 126
31P-NMR
to study kidney metabolism in vivo (abst) 227
Norepinephrine
in model of acute renal failure; effect of acetyl-
choline on 399
pressor response to, in normal man (abst) 173
Obesity
prostaglandins and renin-aldosterone system in
(abst) 229
Osmoregulation




autotransplantation after parathyroidectomy for
(abst) 108
osteomalacic type o.; bone aluminum in (abst) 127
Osteomalacia, dialysis
PTH response to acute hypocalcemia in (abst) 130
Oxygen consumption
in postischemic acute renal failure 306
Ozolinone
renal action of (abst) 251
Papilla, renal
collecting duct of
acid disequilibrium pH's role in Pco2 of (abst) .. .238
vasopressin-sensitive cAMP system in (abst) 239
drug-induced necrosis of; role of urinary concen-
tration (abst) 213
exposed and micropunctured in vivo (abst) 210
functional anatomy of, in mammals (abst) 256
plasma flow of; effects of diuretics on (abst) 57
Para-aminohippurate
clearance of; vs. hippuran to assess renal plasma
XXX Subject index: Vol. 19
flow 49
transport of; aminoglycoside and, related to his-
tologic site of damage (abst) 212
Parathyroidectomy
iliac crest bone biopsy to predict outcome of hy-
pocalcemia after (abst) 110
Parathyroid hormone
cortical adenylate cyclase activity and (abst) 220
in phosphate reabsorption after transplantation 568
Perfusion techniques
damage of distal nephron during 638
Pericarditis, uremic
intrapericardial steroid therapy for (abst) 118
Peritonitis
peritoneal dialysis and 460
protein losses and; during peritoneal dialysis 593
Phentolamine
effect on glomerular dynamics (abst) 260
Phosphate handling, renal
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